Morphine withdrawal sensitizes mice to lipopolysaccharide: Elevated TNF-α and nitric oxide with decreased IL-12

Journal of Neuroimmunology

Volumn 164, Issue 1-2, 2005, Pages 57-65

  Feng, Pu ^a   Meissler Jr , Joseph J ^a   Adler, Martin W ^a   Eisenstein, Toby K ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Endotoxin shock; Lipopolysaccharide; Morphine; Nitric oxide; TNF ; Withdrawal

Indexed keywords

CYTOKINE; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MORPHINE; NITRIC OXIDE; PLACEBO; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL CELL; ARTICLE; BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; LETHALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK;

ANIMALS; ANTIBODIES; DRUG SYNERGISM; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C3H; MORPHINE; NITRIC OXIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 20444496363     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.03.017     Document Type: Article

References (47)

1. S. Ammon-Treiber, H. Tischmeyer, U. Riechert, and V. Hollt Gene expression of transcription factors in the rat brain after morphine withdrawal Neurochem. Res. 29 2004 1267 1273
2. A. Ashkenazi, S.A. Marsters, D.J. Capon, S.M. Chamow, I.S. Figari, D. Pennica, D.V. Goeddel, M.A. Palladino, and D.H. Smith Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin Proc. Natl. Acad. Sci. U. S A. 88 1991 10535 10539
3. A.H. Avila, N.C. Alonzo, and B.M. Bayer Immune cell activity during the initial stages of withdrawal from chronic exposure to cocaine or morphine J. Neuroimmunol. 147 2004 109 113
4. M.C. Barr, S. Huitron-Resendiz, M. Sanchez-Alavez, S.J. Henriksen, and T.R. Phillips Escalating morphine exposures followed by withdrawal in feline immunodeficiency virus-infected cats: a model for HIV infection in chronic opiate abusers Drug Alcohol Depend. 72 2003 141 149
5. L. Bergstrom, T. Sakurada, and L. Terenius Substance P levels in various regions of the rat central nervous system after acute and chronic morphine treatment Life Sci. 35 1984 2375 2382
6. B. Beutler, I.W. Milsark, and A.C. Cerami Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin Science 229 1985 869 871
7. H.N. Bhargava, P.T. Thomas, S. Thorat, and R.V. House Effects of morphine tolerance and abstinence on cellular immune function Brain Res. 642 1994 1 10
8. M. Bhaskaran, K. Reddy, S. Sharma, J. Singh, N. Radhakrishnan, A. Kapasi, and P.C. Singhal Morphine-induced degradation of the host defense barrier: role of macrophage injury J. Infect. Dis. 184 2001 1524 1531
9. J. Blasig, A. Herz, K. Reinhold, and S. Zieglgansberger Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats Psychopharmacologia 33 1973 19 38
10. N.J. Brown, I.M. Coupar, and R.D. Rumsey The effect of acute and chronic administration of morphine and morphine withdrawal on intestinal transit time in the rat J. Pharm. Pharmacol. 40 1988 844 848
11. T.J. Cicero, and E.R. Meyer Morphine pellet implantation in rats: quantitative assessment of tolerance and dependence J. Pharmacol. Exp. Ther. 184 1973 404 408
12. C.S. Constantinescu, B.D. Hondowicz, M.M. Elloso, M. Wysocka, G. Trinchieri, and P. Scott The role of IL-12 in the maintenance of an established Th1 immune response in experimental leishmaniasis Eur. J. Immunol. 28 1998 2227 2233
13. P. Damas, D. Ledoux, M. Nys, Y. Vrindts, D. De Groote, P. Franchimont, and M. Lamy Cytokine serum level during severe sepsis in human IL-6 as a marker of severity Ann. Surg. 215 1992 356 362
14. R.M. Donahoe, L.D. Byrd, H.M. McClure, P. Fultz, M. Brantley, F. Marsteller, A.A. Ansari, D. Wenzel, and M. Aceto Consequences of opiate-dependency in a monkey model of AIDS Adv. Exp. Med. Biol. 335 1993 21 28
15. H. Friedman, C. Newton, and T.W. Klein Microbial infections, immunomodulation, and drugs of abuse Clin. Microbiol. Rev. 16 2003 209 219
16. P. Govitrapong, T. Suttitum, N. Kotchabhakdi, and T. Uneklabh Alterations of immune functions in heroin addicts and heroin withdrawal subjects J. Pharmacol. Exp. Ther. 286 1998 883 889
17. F.P. Heinzel, R.M. Rerko, P. Ling, J. Hakimi, and D.S. Schoenhaut Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon Infect. Immun. 62 1994 4244 4249
18. M.E. Hilburger, M.W. Adler, A.L. Truant, J.J. Meissler Jr., V. Satishchandran, T.J. Rogers, and T.K. Eisenstein Morphine induces sepsis in mice J. Infect. Dis. 176 1997 183 188
19. M. Howard, T. Muchamuel, S. Andrade, and S. Menon Interleukin 10 protects mice from lethal endotoxemia J. Exp. Med. 177 1993 1205 1208
20. D. Laouini, H. Alenius, P. Bryce, H. Oettgen, E. Tsitsikov, and R.S. Geha IL-10 is critical for Th2 responses in a murine model of allergic dermatitis J. Clin. Invest. 112 2003 1058 1066
21. J.D. MacMicking, C. Nathan, G. Hom, N. Chartrain, D.S. Fletcher, M. Trumbauer, K. Stevens, Q.W. Xie, K. Sokol, and N. Hutchinson Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase Cell 81 1995 641 650
22. L. Manara, G. Bianchi, P. Ferretti, and A. Tavani Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites J. Pharmacol. Exp. Ther. 237 1986 945 949
23. H.R. Michie, K.R. Manogue, D.R. Spriggs, A. Revhaug, S. O'Dwyer, C.A. Dinarello, A. Cerami, S.M. Wolff, and D.W. Wilmore Detection of circulating tumor necrosis factor after endotoxin administration N. Engl. J. Med. 318 1988 1481 1486
24. E.J. Nestler, and G.K. Aghajanian Molecular and cellular basis of addiction Science 278 1997 58 63
25. D.A. Papanicolaou, R.L. Wilder, S.C. Manolagas, and G.P. Chrousos The pathophysiologic roles of interleukin-6 in human disease Ann. Intern. Med. 128 1998 127 137
26. C.A. Paronis, and S.G. Holtzman Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats J. Pharmacol. Exp. Ther. 262 1992 1 9
27. J.R. Parratt Nitric oxide. A key mediator in sepsis and endotoxaemia? J. Physiol. Pharmacol. 48 1997 493 506
28. J.R. Parratt Nitric oxide in sepsis and endotoxaemia J. Antimicrob. Chemother. 41 Suppl. A 1998 31 39
29. J.E. Parrillo Pathogenetic mechanisms of septic shock N. Engl. J. Med. 328 1993 1471 1477
30. G.A. Patrick, W.L. Dewey, F.P. Huger, E.D. Daves, and L.S. Harris Disposition of morphine in chronically infused rats: relationship to antinociception and tolerance J. Pharmacol. Exp. Ther. 205 1978 556 562
31. K. Pfeffer, T. Matsuyama, T.M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P.S. Ohashi, M. Kronke, and T.W. Mak Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection Cell 73 1993 457 467
32. A. Poltorak, X. He, I. Smirnova, M.Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, and B. Beutler Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene Science 282 1998 2085 2088
33. D.M. Potvin, D.W. Metzger, W.T. Lee, D.N. Collins, and A.I. Ramsingh Exogenous interleukin-12 protects against lethal infection with coxsackievirus B4 J. Virol. 77 2003 8272 8279
34. R.T. Rahim, M.W. Adler, J.J. Meissler Jr., A. Cowan, T.J. Rogers, E.B. Geller, and T.K. Eisenstein Abrupt or precipitated withdrawal from morphine induces immunosuppression J. Neuroimmunol. 127 2002 88 95
35. R.T. Rahim, J.J. Meissler, L. Zhang, M.W. Adler, T.J. Rogers, and T.K. Eisenstein Withdrawal from morphine in mice suppresses splenic macrophage function, cytokine production, and costimulatory molecules J. Neuroimmunol. 144 2003 16 27
36. R.T. Rahim, P. Feng, J.J. Meissler, T.J. Rogers, L. Zhang, M.W. Adler, and T.K. Eisenstein Paradoxes of immunosuppression in mouse models of withdrawal J. Neuroimmunol. 147 2004 114 120
37. S. Roy, R.G. Charboneau, and R.A. Barke Morphine synergizes with lipopolysaccharide in a chronic endotoxemia model J. Neuroimmunol. 95 1999 107 114
38. S. Roy, S. Balasubramanian, S. Sumandeep, R. Charboneau, J. Wang, D. Melnyk, G.J. Beilman, R. Vatassery, and R.A. Barke Morphine directs T cells toward T(H2) differentiation Surgery 130 2001 304 309
39. S. Roy, J. Wang, S. Gupta, R. Charboneau, H.H. Loh, and R.A. Barke Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet J. Neuroimmunol. 147 2004 78 81
40. S.R. Smith, C. Terminelli, L. Kenworthy-Bott, A. Calzetta, and J. Donkin The cooperative effects of TNF-alpha and IFN-gamma are determining factors in the ability of IL-10 to protect mice from lethal endotoxemia J. Leukoc. Biol. 55 1994 711 718
41. T.J. Standiford, R.M. Strieter, N.W. Lukacs, and S.L. Kunkel Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor J. Immunol. 155 1995 2222 2229
42. K.J. Tracey, B. Beutler, S.F. Lowry, J. Merryweather, S. Wolpe, I.W. Milsark, R.J. Hariri, T.J. Fahey III, A. Zentella, and J.D. Albert Shock and tissue injury induced by recombinant human cachectin Science 234 1986 470 474
43. K.J. Tracey, Y. Fong, D.G. Hesse, K.R. Manogue, A.T. Lee, G.C. Kuo, S.F. Lowry, and A. Cerami Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia Nature 330 1987 662 664
44. F. Tsuji, K. Oki, A. Okahara, H. Suhara, T. Yamanouchi, M. Sasano, S. Mita, and M. Horiuchi Differential effects between marimastat, a TNF-alpha converting enzyme inhibitor, and anti-TNF-alpha antibody on murine models for sepsis and arthritis Cytokine 17 2002 294 300
45. E.L. Way, H.H. Loh, and F.H. Shen Simultaneous quantitative assessment of morphine tolerance and physical dependence J. Pharmacol. Exp. Ther. 167 1969 1 8
46. J.P. West, L.A. Dykstra, and D.T. Lysle Immunomodulatory effects of morphine withdrawal in the rat are time dependent and reversible by clonidine Psychopharmacology (Berl.) 146 1999 320 327
47. M. Wysocka, M. Kubin, L.Q. Vieira, L. Ozmen, G. Garotta, P. Scott, and G. Trinchieri Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice Eur. J. Immunol. 25 1995 672 676